S

Sam-A Pharm Co Ltd
KOSDAQ:009300

Watchlist Manager
Sam-A Pharm Co Ltd
KOSDAQ:009300
Watchlist
Price: 15 380 KRW -0.13% Market Closed
Market Cap: 98B KRW

Operating Margin

15.9%
Current
Declining
by 7.7%
vs 3-y average of 23.6%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
15.9%
=
Operating Income
₩12.2B
/
Revenue
₩76.7B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
15.9%
=
Operating Income
₩12.2B
/
Revenue
₩76.7B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Sam-A Pharm Co Ltd
KOSDAQ:009300
93.9B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
522.8B USD
Loading...
CH
Roche Holding AG
SIX:ROG
273.7B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
207.6B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219.4B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
275.5B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.2B USD
Loading...
No Stocks Found

Market Distribution

Higher than 89% of companies in Korea
Percentile
89th
Based on 2 615 companies
89th percentile
15.9%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Sam-A Pharm Co Ltd
Glance View

Market Cap
98B KRW
Industry
Pharmaceuticals

Sam-A Pharm.Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Wonju, Gangwon-Do. The company went IPO on 2000-07-19. Co., Ltd is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The firm's products include remedies for respiratory, antibiotics, dermatitis treatments, dyspeptic agents, cold remedies, antifebriles, antiphlogistics, analgesics, antihistamines, and remedies for the circulatory, gastrointestinal, urinary systems, cardiovascular and other general pharmaceuticals. The company also provides children nutrition products under the brand name of NOMA.

Intrinsic Value
14 330.35 KRW
Overvaluation 7%
Intrinsic Value
Price
S
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
15.9%
=
Operating Income
₩12.2B
/
Revenue
₩76.7B
What is Sam-A Pharm Co Ltd's current Operating Margin?

The current Operating Margin for Sam-A Pharm Co Ltd is 15.9%, which is below its 3-year median of 23.6%.

How has Operating Margin changed over time?

Over the last 3 years, Sam-A Pharm Co Ltd’s Operating Margin has decreased from 22.7% to 15.9%. During this period, it reached a low of 15.9% on Oct 30, 2025 and a high of 27.2% on Jun 30, 2024.

Back to Top